MILLENNIUM EVALUATING HIGH-THROUGHPUT DRUG SCREENING OPERATIONS START-UP, COMPOUND LIBRARIES -- IPO; GENSET, SYNTHELABO TO IDENTIFY PROSTATE CANCER GENES
Executive Summary
Millennium is "evaluating the establishment of a high-throughput drug-screening operation" for small molecule drugs, the genomics company discloses in its initial public offering prospectus.